Dystrophin expression in a Duchenne muscular dystrophy patient with a frame shift deletion

Neurology

Volumn 48, Issue 2, 1997, Pages 486-488

  Prior, T W ^a   Bartolo, C ^a   Papp, A C ^a   Snyder, P J ^a   Sedra, M S ^a   Burghes, A H M ^a   Kissel, J T ^a   Luquette, M H ^a   Tsao, C Y ^a   Mendell, J R ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; DYSTROPHIN;

ARTICLE; CASE REPORT; CHILD; CONFORMATIONAL TRANSITION; DUCHENNE MUSCULAR DYSTROPHY; EXON; FRAMESHIFT MUTATION; GENE DELETION; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MALE; MUSCLE BIOPSY; PRIORITY JOURNAL;

EID: 0031038385     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.48.2.486     Document Type: Article

References (12)

1. Koenig M, Hoffman KP, Boitclson CJ, et al. Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary gonomic organisation of the DMD gene in normal and affected individuals. Cell 1987;50:509-517.
2. Darras BT, Blattner P, Harper JF, et al. Intragenic deletions in 21 Duchenne muscular dystrophy (DMD)/Becker muscular dystrophy (BMD) families studied with the dystrophin cDNA: location of breakpoints on HindIII and BglII exon-containing fragment maps, meiotic and mitotic origin of mutations. Am J Hum Genet 1988;43:620-629.
3. Forrest SM, Cross GS, Flint T, et al. Further studies of gene deletions that cause Duchenne and Becker muscular dystrophies. Genomics 1988;2:109-114.
4. Gillard EF, Chamberlain JS, Murphy EG, et al. Molecular and phenotypic analysis of patients with deletions within the deletion-rich region of the Duchenne muscular dystrophy (DMD) gene. Am J Hum Genet 1989;45:507-520.
5. Hu X, Ray PN, Murphy EG, et al. Duplicational mutation at the Duchenne muscular dystrophy locus: its frequency, distribution, origin and phenotype/genotype correlation. Am J Hum Genet 1990;46:682-695.
6. Monaco AP, Bertelson CJ, Liechti-Gallati S, et al. An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus. Genomics 1988;2:90-95.
7. Hodgson S, Hart K, Abbs S, et al. Correlation of clinical and deletion data in Duchenne and Becker muscular dystrophy. Am J Hum Genet 1989;26:682-693.
8. Baumbach LL, Chamberlain JS, Ward PA, et al. Molecular and clinical correlations of deletions leading to Duchenne and Becker muscular dystrophies. Neurology 1989;39:465-474.
9. Winnard AV, Klein CJ, Coovert DD, et al. Characterization of translational frame exception patients in Duchenne/Becker muscular dystrophy. Hum Mol Genet 1993;2:737-744.
10. Roberts RG, Barby TFM, Manners E, et al. Direct detection of dystrophin gene rearrangements by analysis of dystrophin mRNA in peripheral blood lymphocytes. Am J Hum Genet 1991;49:298-310.
11. Burrow K, Coovert DD, Klein CJ, et al. Dystrophin expression and somatic reversion in prednisone-treated and untreated Duchenne dystrophy. Neurology 1991;41:662-666.
12. Klein CJ, Coovert DD, Bulman DE, et al. Somatic reversion/ suppression in Duchenne muscular dystrophy (DMD): evidence supporting a frame-restoring mechanism in rare dystrophin-positive fibers. Am J Hum Genet 1992;50:950-959.